{"transactions":[{"id":2463898,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":132185,"kind":"person","name":"Dias Subaweerage","position":1,"cik":"0001825443","reported_name":"Dias Subaweerage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-21T02:08:47.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of SPRB common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"10,000 of the restricted stock units shall vest 25% on June 30, 2022, 25% shall vest on December 31, 2022 and 50% shall vest on June 30, 2023, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"10,000 of the restricted stock units shall vest upon the achievement of specified performance goals."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"10,000 of the restricted stock units shall vest 25% on June 30, 2022, 25% shall vest on December 31, 2022 and 50% shall vest on June 30, 2023, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"10,000 of the restricted stock units shall vest upon the achievement of specified performance goals."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-070718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919121070718/doc4.xml","form_type":"4"}},{"id":2463897,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":132185,"kind":"person","name":"Dias Subaweerage","position":1,"cik":"0001825443","reported_name":"Dias Subaweerage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-21T02:08:47.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares vest on a monthly basis from December 16, 2021, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan)."}],"balance_after":75000,"derivative":{"exercise_price":2.48,"expiration_date":"2031-12-15","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-070718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919121070718/doc4.xml","form_type":"4"}},{"id":2890358,"issuer":{"id":6471,"kind":"organization","name":"SPRUCE BIOSCIENCES, INC."},"owners":[{"id":132185,"kind":"person","name":"Dias Subaweerage","position":1,"cik":"0001825443","reported_name":"Dias Subaweerage","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-30T02:46:49.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest over a four-year period commencing January 28, 2021, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":27500,"derivative":{"exercise_price":20.08,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-21-006373","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683553/000120919121006373/doc4.xml","form_type":"4"}}]}